Clorox Company (The) (NYSE:CLX) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Monday.

According to Zacks, “Clorox delivered a solid start to fiscal 2018 as both first-quarter fiscal 2018 earnings and sales topped estimates and improved year over year. Notably, earnings marked the fourth straight quarterly beat, while sales surpassed estimates for the second consecutive quarter. Earnings primarily gained from solid sales and gross margin expansion, while sales was driven by growth across the United Sates and International businesses, alongside rise in volumes. Additionally, the company’s 2020 Strategy, which is aimed at bolstering growth for the improvement of categories and overall market share, bodes well. However, Clorox has lagged the industry in the last six months. Despite a strong start to fiscal 2018, the company cut its view for the fiscal due to hurricane-related impacts and the divestiture of Aplicare business. Further, inflation and high commodity and logistics costs may dent gross margin.”

Several other equities analysts have also issued reports on the company. Morgan Stanley reduced their target price on Clorox Company (The) from $138.00 to $128.00 and set an “equal weight” rating for the company in a report on Thursday. Jefferies Group LLC reaffirmed a “hold” rating and issued a $132.00 target price on shares of Clorox Company (The) in a report on Wednesday, November 1st. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $115.00 target price on shares of Clorox Company (The) in a report on Sunday, October 8th. BMO Capital Markets reaffirmed a “buy” rating and issued a $150.00 target price on shares of Clorox Company (The) in a report on Thursday, October 5th. Finally, Barclays PLC reaffirmed an “equal weight” rating and issued a $136.00 target price (down from $140.00) on shares of Clorox Company (The) in a report on Friday, August 4th. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating and two have issued a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $128.72.

Shares of Clorox Company (CLX) traded up $0.06 on Monday, reaching $128.17. The company’s stock had a trading volume of 218,428 shares, compared to its average volume of 1,124,065. The company has a debt-to-equity ratio of 3.02, a current ratio of 1.10 and a quick ratio of 0.77. The company has a market cap of $16,518.32, a price-to-earnings ratio of 23.08, a P/E/G ratio of 3.50 and a beta of 0.39. Clorox Company has a 1 year low of $111.24 and a 1 year high of $141.76.

Clorox Company (The) (NYSE:CLX) last issued its quarterly earnings data on Wednesday, November 1st. The company reported $1.46 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.05. The firm had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.48 billion. Clorox Company (The) had a return on equity of 161.59% and a net margin of 11.84%. The company’s revenue for the quarter was up 4.0% on a year-over-year basis. During the same period in the previous year, the company posted $1.36 EPS. analysts expect that Clorox Company will post 5.58 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “Clorox Company (The) (CLX) Upgraded to “Hold” at Zacks Investment Research” was published by Watch List News and is the property of of Watch List News. If you are viewing this story on another domain, it was stolen and republished in violation of United States and international copyright law. The original version of this story can be accessed at https://www.watchlistnews.com/clorox-company-the-clx-upgraded-to-hold-at-zacks-investment-research/1682923.html.

In other Clorox Company (The) news, COO Dawn C. Willoughby sold 2,158 shares of the stock in a transaction on Tuesday, August 29th. The stock was sold at an average price of $138.00, for a total transaction of $297,804.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP Jon M. Balousek sold 9,223 shares of the stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $138.87, for a total value of $1,280,798.01. Following the sale, the senior vice president now owns 20,614 shares in the company, valued at approximately $2,862,666.18. The disclosure for this sale can be found here. In the last quarter, insiders sold 21,242 shares of company stock worth $2,944,449. 1.00% of the stock is owned by company insiders.

Several large investors have recently bought and sold shares of the business. Jacobi Capital Management LLC lifted its position in shares of Clorox Company (The) by 0.3% during the first quarter. Jacobi Capital Management LLC now owns 1,282 shares of the company’s stock worth $172,000 after acquiring an additional 4 shares in the last quarter. Valley National Advisers Inc. lifted its position in shares of Clorox Company (The) by 0.6% during the first quarter. Valley National Advisers Inc. now owns 860 shares of the company’s stock worth $116,000 after acquiring an additional 5 shares in the last quarter. Bernzott Capital Advisors lifted its position in shares of Clorox Company (The) by 0.4% during the second quarter. Bernzott Capital Advisors now owns 1,607 shares of the company’s stock worth $214,000 after acquiring an additional 7 shares in the last quarter. Janney Capital Management LLC lifted its position in shares of Clorox Company (The) by 0.5% during the second quarter. Janney Capital Management LLC now owns 1,611 shares of the company’s stock worth $214,000 after acquiring an additional 8 shares in the last quarter. Finally, Financial Advisory Service Inc. lifted its position in shares of Clorox Company (The) by 0.3% during the second quarter. Financial Advisory Service Inc. now owns 4,012 shares of the company’s stock worth $535,000 after acquiring an additional 12 shares in the last quarter. Hedge funds and other institutional investors own 71.54% of the company’s stock.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.